Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HFpEF”

344 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 344 results

Not applicableLooking for participantsNCT05784753
What this trial is testing

HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction

Who this might be right for
HFpEF - Heart Failure With Preserved Ejection Fraction
University of Nebraska 300
Not applicableStudy completedNCT05002075
What this trial is testing

Efficacy of an m-Health Cardiac Rehabilitation Program in Heart Failure With Preserved Ejection Fraction

Who this might be right for
Heart Failure With Preserved Ejection Fraction
University of Texas Southwestern Medical Center 69
Testing effectiveness (Phase 2)WithdrawnNCT05312021
What this trial is testing

Selective PDE9 Inhibition With IMR-687 in Adults With Heart Failure With Preserved Ejection Fraction

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Cardurion Pharmaceuticals, Inc.
Not applicableNot Yet RecruitingNCT06655532
What this trial is testing

Effects of an Exercise Program in Women Over 60 yr. With HFpEF and Sarcopenia on Functional Capacity and Quality of Life

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFpEF)SarcopeniaWomen
Fundación para la Investigación del Hospital Clínico de Valencia 40
Not applicableNot Yet RecruitingNCT07324772
What this trial is testing

PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF

Who this might be right for
Atrial Fibrillation (AF)Atrial Fibrillation (Paroxysmal)Persistent Atrial Fibrillation+1 more
Northwestern University 30
Not applicableUnknownNCT04594499
What this trial is testing

The Relationship Between Pericardial Fat Thickness and Arterial Stiffness in HFpEF Patients

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Chongqing Medical University 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07417215
What this trial is testing

The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFPEF)HemodialysisSacubitril/Valsartan
University Clinical Hospital Mostar 60
Large-scale testing (Phase 3)Looking for participantsNCT07288398
What this trial is testing

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Who this might be right for
Pulmonary Hypertension Associated With HFpEF
Tenax Therapeutics, Inc. 540
Not applicableNot Yet RecruitingNCT06510270
What this trial is testing

Dapagliflozin in Reducing Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction

Who this might be right for
Heart Failure with Preserved Ejection Fraction
Aswan University 70
Testing effectiveness (Phase 2)Study completedNCT00839228
What this trial is testing

Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction Syndrome

Who this might be right for
Diastolic Heart Failure
University of Aberdeen 70
Testing effectiveness (Phase 2)Study completedNCT06731738
What this trial is testing

Mangafodipir - an Intracellular Contrast Agent for Magnetic Resonance Imaging (MRI): Measuring Manganese Uptake Rate in Heart Failure Patients With Preserved Ejection Fraction (HFpEF) Patients.

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFPEF)
IC TARGETS AS 44
Testing effectiveness (Phase 2)Study completedNCT04945460
What this trial is testing

Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

Who this might be right for
Hypertension, Pulmonary
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 164
Early research (Phase 1)Study completedNCT03843060
What this trial is testing

Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFpEF)
AstraZeneca 14
Not applicableUnknownNCT04239807
What this trial is testing

3-Month Home-based Training With Whole Body Vibration (WBV) Device in Patients With Heart Failure and Preserved Ejection Fraction (GALILEO-HFpEF-HOME) (GALILEOHOME)

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Klinikum der Universität Köln 60
Testing effectiveness (Phase 2)Study completedNCT03015402
What this trial is testing

Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

Who this might be right for
Pulmonary Hypertension SecondaryHeart Failure
University of Pittsburgh 33
Not applicableUnknownNCT04269057
What this trial is testing

Change of NLRP3 Inflammasome Expression Level, Symptoms, and Functional Status in HFpEF Patients Treated With ARNI

Who this might be right for
Heart Failure
Chongqing Medical University 90
Not applicableLooking for participantsNCT04587648
What this trial is testing

Cardiac Amyloidosis in HFpEF

Who this might be right for
Heart Failure With Preserved Ejection FractionAmyloidosis Cardiac
National Taiwan University Hospital 250
Testing effectiveness (Phase 2)Study completedNCT05284617
What this trial is testing

Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Rivus Pharmaceuticals, Inc. 67
Large-scale testing (Phase 3)Study completedNCT03988634
What this trial is testing

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Novartis Pharmaceuticals 467
Large-scale testing (Phase 3)Study completedNCT03057951
What this trial is testing

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Who this might be right for
Heart Failure
Boehringer Ingelheim 5,988
Load More Results